首页|Study on the in vitro activity of Hehuan Yin aqueous extract against hepatitis C 2a virus

Study on the in vitro activity of Hehuan Yin aqueous extract against hepatitis C 2a virus

扫码查看
Objective: To study the anti-HCV activity and mechanism of Hehuan Yin aqueous extract. Methods: Huh7.5.1 cells were used to establish the HCV2a virus infection model. Cell survival rate (%) and Renilla Luciferase Assay Kit (%) were calculated by Celltiter-GLO Assay for evaluating CC50, EC50 and SI values. To observe the drug resistance of the virus to different concentrations of Hehuan Yin within 72 hours by detecting luciferase activity, western-blot was used to detect the protein expression levels of NS5A, NS3 and NS5B. Results: the CC50, EC50 and SI of Hehuan Yin against HCV2a were 132.50g/ml, 1.90g/ml and 67.90 respectively. The EC50 after 24h, 48h and 72h administration were 18g/ml, 5.8g/ml and 2.3g/ml respectively. Within the range of drug concentration, the aqueous extract Hehuan Yin had inhibitory effect on the expression of NS5A and NS5B proteins in a dose-effect relationship, but had no obvious effect on the expression of NS3 protein. Conclusion: The aqueous extract of Hehuan Yin may inhibit the replication of HCV2a virus by changing the protein expression levels of NS5A and NS5B, and the virus has no tolerance to the aqueous extract of Hehuan Yin.

Hehuan Yin aqueous extractHepatitis C 2a virusIn vitro experimentsAntiviral activity

Yuan-Yuan Wu、Yong-Lin Liang、Fei-Long Chen、Qing-Fa Tang

展开 >

School of Traditional Chinese Medicine,Southern Medical University,Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics,Guangdong Provincial Engineering Laboratory of Chinese Medicine Preparation Technology,Guangzhou 510515,China

Natural Foundation of Guangdong Province

2018A030313308

2022

海南医科大学学报(英文版)

海南医科大学学报(英文版)

ISSN:
年,卷(期):2022.28(1)
  • 13